Pulse Biosciences Inc

NASDAQ: PLSE
$17.98
-$0.07 (-0.4%)
Closing Price on November 7, 2024

PLSE Stock Chart and Intraday Price

PLSE Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 3957 POINT EDEN WAY, HAYWARD, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 565.68M USD
Shares Outstanding 55,080,000
Pulse Biosciences, Inc. is a pioneering bioelectric medicine company known for its CellFX System. This innovative platform uses nano-second pulses of electrical energy to precisely target and eliminate specific cells without harming surrounding tissue. Developed with its unique Nano-Pulse Stimulation technology, the system offers a non-thermal approach to treating various medical conditions. Originally named Electroblate, Inc., the company rebranded to Pulse Biosciences in 2015 and is based in Hayward, California.

PLSE Articles

What Has Insiders Eyeing This Biotech Stock
A biotech stock rallying on encouraging trial results prompted insider buying and selling. A specialty retailer and others saw insider buying too.
Trey Thoelcke
Published: